出处
《中国公共卫生》
CAS
CSCD
北大核心
2004年第11期1393-1394,共2页
Chinese Journal of Public Health
基金
国家自然科学基金 (30 1 70 81 8)
上海市卫生局资助项目
参考文献25
-
1Halminen M,Juhela S, Vaarala O, et al. Induction of interferongamma and IL - 4 production by mitogen and specific antigens in peripheral blood lymphocytes of Type 1 diabetes patients[J]. Autoimmunity, 2001,34 (1): 1 - 8.
-
2Hill NJ, Van Gunst K, Sarvetnick N. Th1 and Th2 pancreatic inflammation differentially affects homing of islet - reactive CD4 cells in nonobese diabetic mice [J]. J Immunol, 2003, 170 (4):1649 - 1658.
-
3Koarada S, Wu Y, Olshansky G, et al. Increased nonobese diabetic Th1: Th2( IFN - gamma: IL - 4)ratio is CD4 + T cell intrinsic and independent of APC genetic background [J]. J Immunol,2002, 169(11) :6580 - 6587.
-
4Casares S, Brumeanu TD. Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies[J]. Curr Mol Med, 2001, (3): 367 - 378.
-
5Suarez Pinzon WL, Rabinovitch A. Approaches to type 1 diabetes prevention by intervention in cytokine immunoicregulatory circuits [J]. Iht J Exp Diabetes Res, 2001, 2 (1): 3 - 17.
-
6Serreze DV, Pierce MA, Post CM. Paralytic autommune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN - gamma receptor beta - chain transgene [J]. J Immunol, 2003, 170(5) :2742 - 2749.
-
7Walz M, Overbergh L, Mathieu C, et al. A murine interleukin - 4 - Ig fusion protein regulates the expression of Th1 - and Th2-specific cytokines in the pancreas of NOD mice[J]. Horm Metab Res, 2002, 34(10): 561 - 569.
-
8Horiki M, Yamato E, Noso S, et al. High - level expression of interleukin- 4 following electroporaet ion - mediated gene transfer accelerates Type 1 diabetes in NOD mice[J] .J Autoimmun, 2003,20(2): 111 - 117.
-
9Chen C, Lee WH, Yun P, et al. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes[J] .J Immunol, 2003, 171(2) :733 - 744.
-
10Bergerot I, Arreaza GA, Cameron M J, et al. Insulin B- chain reactive CD4 + regulatory T - cells induced by oral insulin treatment protect from 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T - cells [J]. Diabetes, 1999, 48(9): 1720 - 1729.
同被引文献8
-
1崔春吉,李永宇,崔顺子,朴熙绪,裴风郁.肝硬化患者并发糖尿病及其相关因素分析──附660例报告[J].新医学,2005,36(5):270-272. 被引量:24
-
2AravalliRN,SteerCJ,CressmanEN.Molecularmechanismsofhepatocellularcarcinoma[J].Hepatology,2008,48:2047-2063.
-
3World Health Oi^anization. Definition, diagnosis, and classification ofdiabetes mellitus and its complication [ S ] //World HeathOrganization ? Report of a WHO consultation[J]. Part 1 : Diabetes Mel-litus Geneva World heath Organisation, 1999: 1162.
-
4谭英,吴锦瑜,黎明,张琴.抗病毒治疗乙肝肝硬化伴肝源性糖尿病84例疗效观察[J].山东医药,2008,48(48):23-23. 被引量:5
-
5蔡晓波,陆伦根.糖尿病与肝硬化相互影响[J].肝脏,2010,15(2):137-139. 被引量:4
-
6颜士兰,滕银成.Fas/Fasl凋亡系统与妇科肿瘤研究进展[J].中国优生与遗传杂志,2010,18(10):128-130. 被引量:5
-
7病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. 被引量:1826
-
8张中兴,吴开国.螺旋藻的营养保健功能[J].中国公共卫生,2001,17(5):476-477. 被引量:6
引证文献2
-
1刘素芳,王天云,高燕,郝会敏,李倩,李万里.藻蓝蛋白对Hepa1-6细胞及荷瘤小鼠免疫功能影响[J].中国公共卫生,2012,28(3):342-343. 被引量:3
-
2娄万爽,杨天兴.茵陈蒿汤加减联合饮食调整在肝硬化合并肝源性糖尿病治疗中的临床疗效观察[J].海峡药学,2012,24(8):147-148. 被引量:3
二级引证文献6
-
1卢锟.茵陈蒿汤联合饮食控制在肝硬化合并肝源性糖尿病患者的临床疗效探讨[J].中国医药导刊,2014,16(4):675-676. 被引量:4
-
2郭玮,罗琼,刘帅,高虹,程薇.麦角甾醇对S180荷瘤小鼠抑瘤作用及机制[J].中国公共卫生,2015,31(12):1606-1608. 被引量:8
-
3郭雨菲,孙凤霞,李晓玲,王傲然.茵陈蒿汤在肝胆疾病中临床应用[J].辽宁中医药大学学报,2020,22(3):57-60. 被引量:21
-
4李爽,郝帅,王静,闫燕,赵磊,吴婷婷,王成涛.藻蓝色素蛋白下调RIPK1表达并抑制肺癌A549细胞的增殖和迁移[J].中国食品学报,2020,20(10):50-58.
-
5王静,郝帅,刘媛璞,李爽,赵磊.IRS1在藻蓝蛋白介导的H460细胞增殖和迁移调控中的作用[J].北京师范大学学报(自然科学版),2020,56(6):805-813.
-
6张利君,谢红东,牟微娜,陈萍,徐传华.茵陈蒿汤联合抗感染治疗对肝硬化合并感染患者肝功能及细胞因子的影响分析[J].中华医院感染学杂志,2019,29(9):1355-1358. 被引量:17
-
1成建国.乙型病毒性肝炎的发病机理、诊断与治疗[J].西藏医药,2004,25(3):22-24. 被引量:4
-
2新免疫调节疗法有希望用于心力衰竭[J].中国处方药,2004(10):7-7.
-
3梁宫楠.慢性乙肝联合疗法的运用进展[J].世界今日医学杂志,2002,3(1):27-27. 被引量:1
-
4崔凡,刘维达.侵袭性曲霉病的治疗进展[J].国际皮肤性病学杂志,2006,32(4):260-263. 被引量:2
-
5于春美,房显军.类风湿性关节炎患者关节功能恢复的训练[J].中国组织工程研究与临床康复,2001,10(15).
-
6姜耀珍,周惠成.类风湿关节炎341例康复护理体会[J].现代康复,2001,5(6):148-149. 被引量:1
-
7李在朝.192例小儿病毒性脑炎临床分析[J].中国实用医刊,2008,35(12):60-61. 被引量:1
-
8贺慧霞,陆守昌.sjōgren's综合征研究进展[J].武警后勤学院学报(医学版),1999,20(3):188-189.
-
9潘薇,许忠,郑百红.肺炎支原体肺炎患儿急性期外周血IFN-γIL-4的变化[J].中国当代儿科杂志,2006,8(5):373-375. 被引量:21
-
10唐兰珊.原发性胆汁性肝硬化的药物治疗进展[J].国际医药卫生导报,2011,17(16):2074-2074.